Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

Members only

This research summary is available to CNP Library members. Join to access over 3,000 summaries on diet and mental health.

View membership plans

Already a member? Sign in to the library

Related Studies

Effects of a psychobiotic supplement on serum brain-derived neurotrophic factor levels in depressive patients: A post hoc analysis of a randomized clinical trial

Since the gut microbiota was suggested to interact with brain-derived neurotrophic factor (BDNF), which has been associated with having antidepressant qualities in the past, this 2020 double-blind, randomized controlled trial aimed to elucidate the mechanism of action of a psychobiotic combination (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175; CEREBIOME) that has already significantly improved depressive […]

Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?

The aims of this 2018 review were to analyze the evidence for the anti-inflammatory influence of probiotics, and to describe the potential mechanisms behind probiotics’ antidepressant effects on patients with major depressive disorders (MDDs), with a particular focus on modulation of the immune system. Park et al. (2018) provide us with a narrative review of […]